REGISTER
SIGN IN
Neonatal 17OH Progesterone FEIA
MPIN: MP41074
Sign in to view price
Labsystems Diagnostics’ Neonatal 17-OH-Progesterone FEIA test is a fluorometric enzyme immunoassay enabling the quantification of 17-hydroxyprogestrone steroid present in blood samples dried on filter paper. The test can be used for the screening of newborn for Congenital Adrenal Hyperplasia (CAH).
Ask for Quote
Labsystems Diagnostics’ Neonatal 17-OH-Progesterone FEIA test is a fluorometric enzyme immunoassay enabling the quantification of 17-hydroxyprogestrone steroid present in blood samples dried on filter paper. The test can be used for the screening of newborn for Congenital Adrenal Hyperplasia (CAH).
Benefits
- Excellent reproducibility
- High sensitivity with high signal/background ratio
- Calibrated against the latest international references
OVERVIEW
It is a competitive Fluorometric enzyme immunoassay for the quantitative determination of human 17-OH-progesterone from dried blood spots. It measures the 21-hydroxylase deficiency which is by far the most frequent form of CAH (more than 90 % of cases).
Specification
- Neonatal 17-OH-Progesterone FEIA , 5 strip plates (12×8), 480 wells 6199870
- Neonatal 17-OH-Progesterone FEIA, 10 strip plate (12×8), 960 wells 6199872
- Neonatal 17-OH-Progesterone FEIA, 10 solid plates (96), 960 wells 6199871
Shipping Policy
Orders made at Medpick are initiated and processed for shipment upon receipt of request from the customer. Please note that our Shipping Services (Fee, Transportation, Loss or Damage of any shipment, etc.) are in accordance with the Seller\'s terms of Shipment.
Refund Policy
Please refer to Medpick Return Policy.
Cancellation / Return / Exchange Policy
Please refer to Medpick Return Policy.
Related products
-
Laboratory Infrastructure
Neoscreen TSH
Congenital hypothyroidism (CH) is an endocrine disorder of newborns characterized by the decreased levels of thyroid hormones: thyroxine (T4) and triiodothyronine (T3) in periferal blood. In early perinatal period manifestations of CH are often non-specific, subtle or even non-existent [1-2]. However, the disease, if undiagnosed and untreated, leads to severe
SKU: MP40987 -
Laboratory Infrastructure
Neoscreen Galactose
Galactosemia is an inherited metabolic abnormality comprising three distinctive clinical entities of the galactose pathway defects. Classic galactosemia is due to -Dgalactose- 1-phosphate-uridyl-transferase (GALT) defect (1). The test principle is based on extraction of Galactose & Galactose-1-phosphate from dried blood spot followed by enzymatic conversion of Galactose-1-phosphate & Galactose. Two kinds of extraction methods (acidic and heat) can be used for extraction step.
SKU: MP40990
